Type 2 Diabetes: 2 Studies Unlock Clues About Dementia Risk & Brain Health

Translate to Spanish or other 102 languages!

In the United States, nearly 15% of all adultsTrusted Source 18 years or older had diabetes in 2021, and more than 90%Trusted Source of them had type 2 diabetes. Image for illustration purposes
In the United States, nearly 15% of all adultsTrusted Source 18 years or older had diabetes in 2021, and more than 90%Trusted Source of them had type 2 diabetes. Image for illustration purposes
- Advertisement -
  • To help our audience catch up on the latest medical research developments and insights from health experts, we highlight key findings and takeaways from recent research studies that Medical News Today has covered in depth in previous news reporting.
  • Three published studies in August focused on type 2 diabetes and complications related to the condition that hundreds of millions of people are living with worldwide.
  • One study indicates that maintaining stable hemoglobin A1c (HbA1c) over time can help mitigate dementia risk, while another found that a healthy lifestyle can offset brain aging accelerated by diabetes.

In the United States, nearly 15% of all adultsTrusted Source 18 years or older had diabetes in 2021, and more than 90%Trusted Source of them had type 2 diabetes. Worldwide, it is estimated that the prevalence of diabetes will drastically increase over the next 20 years, according to projections by the International Diabetes Federation.

Follow the link below to Medical News Today for the full story:

https://www.medicalnewstoday.com/articles/type-2-diabetes-studies-healthy-lifestyle-dementia-risk-brain-aging?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-09&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.

Coordinated Care Supports Mother through Cancer and Pregnancy

Mega Doctor News By Kristen Zapata | UT Health San Antonio Two pink...
- Advertisement -